Spine TumorNCT07326969
MOVEMENT ANALYSIS IN PATIENTS UNDERGOING VERTEBRECTOMIES FOR SPINE ONCOLOGY: A PILOT STUDY
An observational study of Spine Tumor and Vertebral Metastasis, run by Istituto Ortopedico Rizzoli at 1 site in Italy.
Trial summary
Analyze the geometric and kinematic parameters of the spine in patients undergoing vertebrectomy through gait analysis, both during the execution of motor tasks such as walking, standing, and basic trunk movements, with the aim of improving the assessment and, therefore, possibly, the treatment and the final clinical… Read more about this study
- Who is it for?
- Ages 18 to 18 years
- Conditions the study is for
- Spine Tumor, Vertebral Metastasis, Vertebral Column Mass
- What is being tested?
- vertebrectomy
- How many people
- 10 participants
- Where
- 1 siteItaly
- Study dates
- 3 Mar 2023to 21 Dec 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 18 years
- All sexes
- No healthy volunteers
- Adult
Study population: patients with vertebral tumors undergoing vertebrectomy
Who may be able to join
- Age 18 years or older
- Presence of spinal cancer with surgical indication for vertebrectomy
- Approval and signature of informed consent for the study
- Ability to undergo movement analysis before the surgery and the 6-month follow-up
Who cannot join
- Under 18 years of age
- Presence of degenerative, traumatic, or infectious pathologies or spinal deformities
- Absence of a signed informed consent form
- Inability to undergo movement analysis before the surgery or the 6-month follow-up
Trial locations and contacts
1 site in 1 country.
About this study
Official title: MOVEMENT ANALYSIS IN PATIENTS UNDERGOING VERTEBRECTOMIES FOR THE TREATMENT OF SPINE ONCOLOGY: A PILOT STUDY
Analyze the geometric and kinematic parameters of the spine in patients undergoing vertebrectomy through gait analysis, both during the execution of motor tasks such as walking, standing, and basic trunk movements, with the aim of improving the assessment and, therefore, possibly, the treatment and the final clinical outcome.
- Conditions
- Spine Tumor, Vertebral Metastasis, Vertebral Column Mass
- Being tested
- vertebrectomy
- Keywords
- vertebrectomy, gait analysis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
vertebrectomyOther
en bloc resection of oncological vertebra
| Study group | Role | What they receive |
|---|---|---|
| vertebrectomy | patients with vertebral tumors undergoing vertebrectomy Receives: Other: vertebrectomy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Gait Analysis
Measure and correlate geometric and kinematic parameters of the trunk and spine through instrumental motion analysis, before and after vertebrectomy surgery in patients with oncological spinal diseases.
Measured: 6 months after vertebrectomy
Secondary outcomes (2)
questionnaire
Evaluate patient-reported functional outcomes through self-administered questionnaires: Oswestry Disability Index and Fall Efficacy Scale-International
Measured: 6 months after vertebrectomy
spino-pelvic parameters
Measure the geometric spino-pelvic parameters (static) and compare them with the kinematic parameters (dynamic)
Measured: 6 months after vertebrectomy
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jan 2026
- Study start3 Mar 2023
- Primary completion20 Dec 2024
- Study completion21 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Spine TumorStudies of the same condition, open and under way.
- More trials run by Istituto Ortopedico RizzoliThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 10 participants (actual)
Sponsor and investigators
- Lead sponsor
- Istituto Ortopedico Rizzoli
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07326969
- Sponsor's protocol ID
- GAV
- Status last verified
- Dec 2025
- First submitted
- 24 Dec 2025
- Last updated
- 8 Jan 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 8 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- MOVEMENT ANALYSIS IN PATIENTS UNDERGOING VERTEBRECTOMIES FOR THE TREATMENT OF SPINE ONCOLOGY: A PILOT STUDY
- ClinicalTrials.gov ID
- NCT07326969
- Acronym / sponsor ID
- GAV
- Conditions
- Spine Tumor, Vertebral Metastasis, Vertebral Column Mass
- Keywords
- vertebrectomy, gait analysis
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 10 participants (actual)
- Lead sponsor
- Istituto Ortopedico RizzoliUniversity, hospital or other
- Study start
- 3 Mar 2023 (actual)
- Primary completion
- 20 Dec 2024 (actual)
- Study completion
- 21 Dec 2025 (actual)
- First posted
- 8 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Analyze the geometric and kinematic parameters of the spine in patients undergoing vertebrectomy through gait analysis, both during the execution of motor tasks such as walking, standing, and basic trunk movements, with the aim of improving the assessment and, therefore, possibly, the treatment and the final clinical outcome.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| vertebrectomy | – | Other: vertebrectomypatients with vertebral tumors undergoing vertebrectomy |
Who may qualify
- Ages
- 18 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- patients with vertebral tumors undergoing vertebrectomy
Key inclusion criteria (4 listed)
- Age 18 years or older
- Presence of spinal cancer with surgical indication for vertebrectomy
- Approval and signature of informed consent for the study
- Ability to undergo movement analysis before the surgery and the 6-month follow-up
Key exclusion criteria (4 listed)
- Under 18 years of age
- Presence of degenerative, traumatic, or infectious pathologies or spinal deformities
- Absence of a signed informed consent form
- Inability to undergo movement analysis before the surgery or the 6-month follow-up
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| vertebrectomyen bloc resection of oncological vertebra | Other | vertebrectomy |
Primary outcome
Gait Analysis
Time frame: 6 months after vertebrectomy
Measure and correlate geometric and kinematic parameters of the trunk and spine through instrumental motion analysis, before and after vertebrectomy surgery in patients with oncological spinal diseases.
2 secondary outcomes
questionnaire
Time frame: 6 months after vertebrectomy
spino-pelvic parameters
Time frame: 6 months after vertebrectomy
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jan 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Spine Tumor
RecruitingPhase 1/2
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
Glioma, Medulloblastoma
Recruiting
Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
RecruitingPhase 3
Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone Metastases
Cancer Metastatic
Active, not recruitingPhase 2
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord
Malignant Digestive System Neoplasm, Metastatic Head and Neck Carcinoma
Active, not recruitingPhase 2
Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal Metastases
Metastatic Malignant Neoplasm in the Spine, Metastatic Malignant Solid Neoplasm
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Spine Tumor and Vertebral Metastasis, run by Istituto Ortopedico Rizzoli at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Gait Analysis (time frame: 6 months after vertebrectomy). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jan 2026.